Immune System Diseases

905 trials 381 recruiting

Filter these 905 trials by phase, country and sponsor.

Open in Search →

The REST (Replacing Steroids in the transplant ineligible) study. Ended

2023-510194-34-00 Multiple myeloma 4 2021-06-18
A Phase 2 Clinical Study to Assess the Safety and Efficacy of Deucravacitinib in Participants with Active DLE and/or SCLE Ended

2023-504161-22-00 Active Discoid and/or Subacute Cutaneous Lupus Erythema 4 2021-06-04
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients with IgA Nephropathy at Risk of Progressive Loss of … Ended

2024-513227-16-00 Immunoglobulin A Nephropathy (IgAN) 5 2021-05-19
A Study to Evaluate Efficacy and Safety of Obinutuzumab in Patients with Primary Membranous Nephropathy Ended

2023-506525-11-00 Primary Membranous Nephropathy (pMN) 5 2021-04-19
Inebilizumab efficacy and safety in adults with myasthenia gravis Ended

2023-510006-40-00 Myasthenia Gravis which is either due to acetylcholine 5 2021-03-22
A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juven… Ended

2023-507184-19-00 Juvenile Psoriatic Arthritis  Enthesitis Related Arthr 5 2021-02-22
A double-blind study to evaluate the effectiveness and safety of CAEL-101 in patients with AL amyloidosis. Ended

2022-503072-84-00 stage IIIa cardiac AL amyloidosis 5 2021-02-13
A double-blind study to evaluate the effectiveness and safety of CAEL-101 in patients with AL amyloidosis Ended

2022-503073-11-00 Stage IIIb cardiac AL amyloidosis 5 2021-02-13
A Double-blind Randomized, Placebo-Controlled Study and Open-label Long Term Extension to Evaluate the Efficacy and Safety of Elafibranor 80… Ended

2024-512232-30-00 Primary Biliary Cholangitis 10 2021-01-18
An extension study to learn if Zilucoplan is safe and works over a long period in adult participants with generalized myasthenia gravis. Ended

2024-512399-37-00 Generalized Myasthenia Gravis 5 2020-12-29
A Phase 3, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study of Inebilizumab Efficacy and Safety in IgG4-Related Disease. Ended

2023-508290-81-00 Immunoglobulin G4-related disease (IgG4-RD) 5 2020-12-18
18F-Fluorocholine (FCH) versus 18F-Fluorodesoxyglucose (FDG) PET/CT for the detection of lesions in patients with multiple myeloma Ended

2024-516682-36-00 Patients diagnosed with multiple myeloma 4 2020-12-15
A Phase 1/2, first-in-human, two-part, open-label clinical trial of intravenous administration of CTL-002 given as monotherapy and/or in com… Ended

2024-512575-12-00 ADVANCED-STAGE, RELAPSED/REFRACTORY SOLID TUMORS 9 2020-11-25
Rituximab from the first episode of Minimal Change Nephrotic Syndrome for preventing relapse risk in adult patients Ended

2024-516102-36-00 Minimal Change Nephrotic Syndrom 4 2020-07-29
A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Patients with ISN/RPS 2003 Class III or IV Lupus Nephritis Ended

2023-503628-22-00 Lupus Nephritis (LN) 5 2020-07-16
A study for subjects after organ or cell transplantation after failure of prior treatment Ended

2024-516622-57-00 Epstein-Barr Virus-Associated Post-Transplant Lymphopro 5 2020-05-06
A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust Mites Ended

2022-500660-35-00 Allergy to House Dust Mites 1 2020-02-17
MEthotrexate versus TOcilizumab for treatment of GIant cell Arteritis: a multicenter, randomized, controlled trial Ended

2024-512269-14-00 GIant cell Arteritis 5 2020-01-27
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults with Primary Progressive Multiple Sclerosis Ended

2023-505980-36-00 Primary progressive multiple sclerosis (PPMS) 5 2019-09-19
Efficacy and Safety of M281 in Adults with Warm Autoimmune Hemolytic Anemia: A Multicenter, Randomized, Double-blind, Placebo-controlled Stu… Ended

2023-505321-14-00 Warm Autoimmune Hemolytic Anemia 10 2019-09-06
Effect of cladribine treatment on microglial activation in the CNS Ended

2024-519921-39-00 Multiple Sclerosis 6 2019-08-16
A Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Respo… Ended

2023-505477-33-00 Psoriatic Arthritis 5 2019-06-18
A Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or … Ended

2023-505478-14-00 Psoriatic Arthritis 5 2019-05-09
A prospective controlled trial to evaluate safety and efficacy of in vitro expanded recipient regulatory T cell therapy and tocilizumab toge… Ended

2024-513459-34-00 Kidney transplantation 9 2019-04-24